NeoStem ups revenues 22% in FY14

• NeoStem (NBS +7.4%) FY14 results: Revenues: $17.9M (+21.8%); COGS: $15.7M (+21.7%); R&D Expense: $29.2M (+72.8%); SG&A: $30.8M (+42.6%); Operating Loss: ($57.7M) (-56.8%); Net Loss: ($54.9M) (-40.8%); Loss Per Share: ($1.68) (+11.6%); Quick Assets: $26.3M (-43.0%).
• No guidance given.